Detalhe da pesquisa
1.
Targeting myeloid chemotaxis to reverse prostate cancer therapy resistance.
Nature
; 623(7989): 1053-1061, 2023 Nov.
Artigo
em Inglês
| MEDLINE | ID: mdl-37844613
2.
Effect of Reasons for Screen Failure on Subsequent Treatment Outcomes in Cancer Patients Assessed for Clinical Trials.
Oncology
; 97(5): 270-276, 2019.
Artigo
em Inglês
| MEDLINE | ID: mdl-31266008
3.
A risk-based approach to experimental early phase clinical trials during the COVID-19 pandemic.
Lancet Oncol
; 21(7): 889-891, 2020 07.
Artigo
em Inglês
| MEDLINE | ID: mdl-32615107
4.
Moving beyond epidermal growth factor receptor resistance in metastatic non-small cell lung cancer - a drug development perspective.
Crit Rev Oncol Hematol
; 159: 103225, 2021 Mar.
Artigo
em Inglês
| MEDLINE | ID: mdl-33482349
5.
A Wolf in Sheep's Clothing: Systemic Immune Activation Post Immunotherapy.
J Immunother Precis Oncol
; 4(4): 189-195, 2021 Nov.
Artigo
em Inglês
| MEDLINE | ID: mdl-35665022
6.
Research Related Tumour Biopsies in Early-Phase Trials with Simultaneous Molecular Characterisation - a Single Unit Experience.
Cancer Treat Res Commun
; 27: 100309, 2021.
Artigo
em Inglês
| MEDLINE | ID: mdl-33549985
7.
Radiological Patterns of Drug-induced Interstitial Lung Disease (DILD) in Early-phase Oncology Clinical Trials.
Clin Cancer Res
; 26(18): 4805-4813, 2020 09 15.
Artigo
em Inglês
| MEDLINE | ID: mdl-32332017
8.
Outcomes of Australian patients receiving non-funded anti-PD-1 immune checkpoint inhibitors for non-melanoma cancers.
Asia Pac J Clin Oncol
; 14(4): 337-342, 2018 Aug.
Artigo
em Inglês
| MEDLINE | ID: mdl-29498208
9.
Early recognition of ipilimumab-related autoimmune hypophysitis in patients with metastatic melanoma: Case studies and recommendations for management.
Asia Pac J Clin Oncol
; 11(2): 190-4, 2015 Jun.
Artigo
em Inglês
| MEDLINE | ID: mdl-25855890